Lack of Pharmacokinetic Interaction Between Oral Apremilast and Methotrexate in Rheumatoid Arthritis and Psoriatic Arthritis Patients

被引：1
|
作者：
Nissel, James [1 ]
Wu, Anfan [1 ]
Laille, Eric [1 ]
Liu, Liangang [1 ]
Kivitz, Alan [3 ]
Fleischmann, Roy [4 ]
Choudhury, Somesh [1 ]
Stevens, Randall [2 ]
Pahaisano, Maria [1 ]
机构：
[1] Celgene Corp, Translat Dev Clin Pharmacol, Summit, NJ USA
[2] Celgene Corp, Clin Res & Dev, Summit, NJ USA
[3] ACRC, Altoona, PA USA
[4] MCRC, Dallas, TX USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 51卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1328 / 1329
页数：2
相关论文
共 50 条
  • [1] The Pharmacokinetic Effect of Coadministration of Apremilast and Methotrexate in Individuals With Rheumatoid Arthritis and Psoriatic Arthritis
    Liu, Yong
    Zhou, Simon
    Nissel, James
    Wu, Anfan
    Lau, Henry
    Palmisano, Maria
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (06): : 456 - 465
  • [2] Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patients
    Schwartz, JI
    Agrawal, NGB
    Wong, PH
    Bachmann, KA
    Porras, AG
    Miller, JL
    Ebel, DL
    Sack, MR
    Holmes, GB
    Redfern, JS
    Gertz, BJ
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (10): : 1120 - 1130
  • [3] Lack of pharmacokinetic interaction of meloxicam with methotrexate in patients with rheumatoid arthritis
    Hubner, G
    Sander, O
    Degner, FL
    Turck, D
    Rau, R
    [J]. JOURNAL OF RHEUMATOLOGY, 1997, 24 (05) : 845 - 851
  • [4] Lack of interaction between flucloxacillin and methotrexate in patients with rheumatoid arthritis
    Herrick, AL
    Grennan, DM
    Griffen, K
    Aarons, L
    Gifford, LA
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (03) : 223 - 227
  • [5] Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis
    GumbhirShah, K
    Cevallos, WH
    DeCleene, SA
    KorthBradley, JM
    [J]. JOURNAL OF RHEUMATOLOGY, 1996, 23 (06) : 984 - 989
  • [6] Oral Apremilast Monotherapy and Psoriatic Arthritis
    不详
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2013, 12 (12) : 1492 - 1493
  • [7] Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
    Calasan, Maja Bulatovic
    van den Bosch, Oscar F. C.
    Creemers, Marjonne C. W.
    Custers, Martijn
    Heurkens, Antonius H. M.
    van Woerkom, Jan Maarten
    Wulffraat, Nico M.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2013, 15 (06)
  • [8] Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis
    Lindsey Tilling
    Sue Townsend
    Joel David
    [J]. Clinical Drug Investigation, 2006, 26 : 55 - 62
  • [9] Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
    Maja Bulatović Ćalasan
    Oscar FC van den Bosch
    Marjonne CW Creemers
    Martijn Custers
    Antonius HM Heurkens
    Jan Maarten van Woerkom
    Nico M Wulffraat
    [J]. Arthritis Research & Therapy, 15
  • [10] Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis
    Tilling, L
    Townsend, S
    David, J
    [J]. CLINICAL DRUG INVESTIGATION, 2006, 26 (02) : 55 - 62
12345